Navigation Links
FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans
Date:10/5/2011

SILVER SPRING, Md., Oct. 5, 2011 /PRNewswire-USNewswire/ -- FDA Commissioner Margaret A. Hamburg, M.D., today released a blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving the health of Americans.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Titled "Driving Biomedical Innovation: Initiatives for Improving Products for Patients," the blueprint addresses concerns about the sustainability of the medical product development pipeline, which is slowing down despite record investments in research and development.

"The Obama Administration is committed to encouraging the entrepreneurs and businesses that are modernizing and strengthening our health care system," said HHS Secretary Kathleen Sebelius. "The innovation blueprint is another part of our effort to help businesses grow and keep Americans healthy."

"America is at an important crossroads, where the science before us presents unprecedented opportunities to create new and better medical products and to promote better health for the public," said Hamburg. "Our innovation blueprint highlights some of the initiatives FDA will be implementing to ensure that these opportunities are translated into safe and effective treatments that can help keep both American patients and American industry healthy and strong."

While FDA has long been committed to promoting innovation with a number of efforts underway already this year, Dr. Hamburg recognized the need to create an FDA-wide framework to address the changing scientific landscape. This blueprint launches the Innovation Initiative, identifying additional steps the agency can take immediately to address the most pressing concerns facing patients and industry.

The report's proposals stem from a review of FDA's current policies and practices, as well as months of meetings with major stakeholders nationwide, including key industry leaders, small biotech, pharmaceutical and medical device company owners, members of the academic community, and patient groups.

The blueprint focuses on implementing the following major actions:

  • rebuilding FDA's small business outreach services
  • building the infrastructure to drive and support personalized medicine
  • creating a rapid drug development pathway for important targeted therapies
  • harnessing the potential of data mining and information sharing while protecting patient privacy
  • improving consistency and clarity in the medical device review process
  • training the next generation of innovators
  • streamlining and reforming FDA regulations.

The blueprint was released during the commissioner's appearance at the 3rd annual Washington Ideas Forum, sponsored by The Atlantic magazine in partnership with the Aspen Institute and the Newseum.

For more information:

Innovation
www.fda.gov/innovation

White House blog posting
http://www.whitehouse.gov/blog/2011/10/05/innovation-food-and-drug-administration  

Media Inquiries: Jeffrey Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NORD Hosts Forum for FDA Commissioner and Patient Leaders
2. Former FDA Commissioner Joins Bexion Pharmaceuticals Board
3. AdvaMed 2010 Premier Medical Technology Conference Opens Today in Washington D.C. With Executive Workshops, Company Presentations, Innovation Alley Exhibits and Featured Keynote Speakers: FDA Commissioner Dr. Margaret Hamburg, CMS Administrator Dr.
4. Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches by the U.S. FDA Commissioner, U.S. CMS Administrator, CBS Evening News Anc
5. PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee
6. FDA Outlines Oversight of Mobile Medical Applications
7. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
8. Oclaro Provides Complete Fiber Laser Diode Solutions Portfolio; Outlines Future Innovation and Technology Advancements
9. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
10. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
11. Medical Affairs Report Outlines Resource Needs for Group Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at a ... to wait until March 2017 for an interest rate increase, according to Rajeev Dhawan ... Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):